Rheumatology

Research Instructor, University of Pittsburgh School of Medicine


Division of Pediatric Rheumatology
Children's Hospital of Pittsburgh
3705 Fifth Avenue
Pittsburgh, PA 15213

412-692-5081
412-692-5565 Fax
margalit.rosenkranz@chp.edu

Medical School:

1998 University of Pittsburgh School of Medicine

Residency:

2001 New York University Medical Center/Bellevue Hospital Center, New York, NY

Fellowship:

2004 Hospital for Special Surgery/Weill Medical School of Cornell University, New York, NY

• Member, American College of Rheumatology
• Fellow, American Academy of Pediatrics

Board Certifications

• American Board of Pediatrics
• American Sub board of Pediatric Rheumatology

• 2004 Advanced Fellowship Training Program Award, Children's Hospital of Pittsburgh

• NIH K23 Proteomic Profiles and Novel Biomarkers in Juvenile Rheumatoid Arthritis

Margalit Rosenkranz, MD, joined the Division of Pediatric Rheumatology at Children's Hospital of Pittsburgh in 2004. She brings a strong background in research focused on developing a deeper understanding of the immunogenetics of juvenile rheumatoid arthritis (JRA) and other rheumatic diseases.

Dr. Rosenkranz earned a bachelor's degree in biology at the University of Pittsburgh in 1994 and her medical degree at the University of Pittsburgh School of Medicine in 1998. She completed her pediatric residency at New York University Medical Center and Bellevue Hospital in 2001 and completed a pediatric rheumatology fellowship at the Hospital for Special Surgery and Weill Medical College of Cornell University in New York in 2004.

At Children's Hospital, Dr. Rosenkranz's research has focused on proteomics in JRA to identify specific protein profiles of a patient. By identifying the proteomic "fingerprint" of a patient and differentially expressed proteins in the various subtypes of juvenile rheumatoid arthritis, she is seeking to determine whether the serum proteome signatures vary among the different forms of JRA. Proteomic signatures also may be useful in identifying patients who are more or less likely to respond to specific treatments. She received an advanced fellowship training program award from Children's Hospital to help support her research activities.